Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05670288 · ClinicalTrials.gov registry record
Impact of Gut Microbiome on Metabolic and Bowel Function During the First Year After Spinal Cord Injury
A clinical trial of Spinal Cord Injuries and Gut Microbiome, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT05670288: Recruiting study of Spinal Cord Injuries and Gut Microbiome, sponsored by University of Alabama at Birmingham.
NCT05670288 is a study of Spinal Cord Injuries and Gut Microbiome that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 35 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05670288, a study of Spinal Cord Injuries and Gut Microbiome, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The Investigators will recruit 35 participants with acute SCI (within 6 weeks of injury) Fasting blood collection and bowel function survey will be conducted 3 times: at baseline \[within 6 weeks of injury\], 6, and 12 months after SCI. Stool will be collected for gut microbiome analysis 3 times.
Primary Outcome
Injury level determined by International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam
Conditions Studied
Study Locations (1)
Alabama
- The University of Alabama at Birmingahm - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2023-10-15 |
| Est. Completion | 2027-02-28 |
What NCT05670288 shows while recruiting
NCT05670288 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (43% lower).
The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 0 interventions.
NCT05670288 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05670288 about?
NCT05670288 is a clinical study titled "Impact of Gut Microbiome on Metabolic and Bowel Function During the First Year After Spinal Cord Injury". The Investigators will recruit 35 participants with acute SCI (within 6 weeks of injury) Fasting blood collection and bowel function survey will be conducted 3 times: at baseline \[within 6 weeks of injury\], 6, and 12 months after SCI. Stool will be collected for gut microbiome analysis 3 times.
What is the current status of trial NCT05670288?
This trial is currently recruiting. The enrollment target is 35 participants. The study started on 2023-10-15. Estimated completion is 2027-02-28.
What conditions does trial NCT05670288 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Gut Microbiome.
Who is sponsoring clinical trial NCT05670288?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05670288 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05670288's enrollment target sits among peer trials
35 87th of 202 higher than 115 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Effectiveness of the Collaborative Community Clinic for Persons With Spinal Cord Injury and Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy